Greatview Aseptic Packaging (468) H2 2025 earnings summary

Executive summary

• Revenue declined 17.1% year-over-year to RMB1,857.0 million, with net profit plunging 80.5% to RMB52.9 million, mainly due to lower sales volume, reduced average sales price, and a change in accounting treatment for the International Business.

• The company underwent significant governance and management changes, completed a major equity restructuring, and faced intensified market competition and industry adjustment.

• Strategic focus was placed on technological innovation, green transformation, and digitalisation, with notable progress in intelligent manufacturing and supply chain resilience.

Financial highlights

• Gross profit dropped 32.0% year-over-year to RMB287.4 million; gross margin fell to 15.5% from 18.9%.

• Earnings per share (EPS) decreased to RMB0.04 from RMB0.19.

• Cash and cash equivalents at year-end were RMB461.7 million, down from RMB748.3 million.

• No bank borrowings at year-end; advances from banks on discounted bills receivables rose to RMB100.8 million.

• Proposed final dividend of HK$0.006 per share, a 97.3% decrease year-over-year.

Outlook and guidance

• Plans to deepen cooperation with existing customers, expand market share in China, and pursue international growth through localisation and product innovation.

• Continued emphasis on digital transformation, green and sustainable development, and operational excellence.